Pentasa Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Prolonged-release tablet: Prolonged Release Tablets 500 mg: Each tablet contains 500 mg mesalazine.
Prolonged Release Tablets 1 g: Each tablet contains 1 g mesalazine.
Prolonged-release granules: Each sachet contains 2 g mesalazine.
Suppository: Each suppository contains 1 g mesalazine.
Rectal suspension: Each bottle of rectal suspension contains 1 g (1g/100ml) mesalazine.
Excipients/Inactive Ingredients: Prolonged-release tablet: Magnesium stearate, talc, ethylcellulose, povidone, microcrystalline cellulose.
Prolonged-release granules: Ethylcellulose and Povidone.
Suppository: Magnesium stearate, talc, povidone, macrogol 6000.
Rectal suspension: Disodium edetate, sodium metabisulphite, sodium acetate, purified water and hydrochloric acid for pH adjustment.

mesalazine

Manufacturer:

Ferring

Distributor:

Zuellig Pharma